Oscar
Briz Sánchez
Profesor Permanente Laboral
Publications (94) Oscar Briz Sánchez publications
2025
-
A novel noninvasive test based on near-infrared fluorescent cholephilic probes for hepatobiliary secretory function assessment
Biomedicine and Pharmacotherapy, Vol. 187
-
Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs
Molecules, Vol. 30, Núm. 14
-
Modulating Wnt/β-catenin pathway activity to enhance chemosensitivity in cholangiocarcinoma
Biomedicine and Pharmacotherapy, Vol. 188
-
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas
Journal of Hepatology, Vol. 83, Núm. 5, pp. 1077-1091
-
Relevance of transportome among the mechanisms of chemoresistance in hepatoblastoma
Biochemical Pharmacology, Vol. 237
-
Role of tumor suppressor genes P53 and PTEN in CD44-mediated gastric adenocarcinoma multidrug resistance
Biomedicine and Pharmacotherapy, Vol. 187
2024
-
Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy
CANCER DRUG RESISTANCE, Vol. 7
-
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Biomedicine and Pharmacotherapy, Vol. 170
-
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Biomedicine and Pharmacotherapy, Vol. 180
-
Strategies to enhance the response of liver cancer to pharmacological treatments
American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33
-
Synthesis, Characterization, and Potential Usefulness in Liver Function Assessment of Novel Bile Acid Derivatives with Near-Infrared Fluorescence (NIRBAD)
Bioconjugate Chemistry, Vol. 35, Núm. 7, pp. 971-980
2023
-
Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs
Biomedicine and Pharmacotherapy, Vol. 168
-
Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells
Biomedicine and Pharmacotherapy, Vol. 165
-
Relevance of the organic anion transporting polypeptide 1B3 (OATP1B3) in the personalized pharmacological treatment of hepatocellular carcinoma
Biochemical Pharmacology, Vol. 214
-
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers, Vol. 15, Núm. 12
-
Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors
Biochemical Pharmacology, Vol. 217
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Editorial: Natural Products and Hepatic Health: Light and Shadows
Frontiers in Pharmacology
-
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Cancers, Vol. 14, Núm. 14
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24